ATM and systemic sclerosis: On the other hand, inhibition of ATM in SSc fibroblasts with the competitive inhibitor KU55933 (KuDOS 55933) significantly increased the expression of the WIF-1 gene, suggesting a therapeutic benefit from targeting components of the DDR/R [135].